{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:11:10Z","timestamp":1753891870608,"version":"3.41.2"},"reference-count":73,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T00:00:00Z","timestamp":1684454400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002332","name":"Semmelweis Egyetem","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002332","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>The possible correlation between melanoma and Parkinson\u2019s disease (PD) has been intensively studied. In this work, we aimed to assess the coincidence of skin malignancies and PD at a dermato-oncological university centre in Central-Eastern Europe, Hungary.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>From 2004 to 2017, a retrospective analysis of the centre\u2019s database was performed based on International Statistical Classification of Diseases-10 codes.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Out of the patients who visited the clinic during the study period, 20,658 were treated for malignant skin tumours. Over the 14 years, 205 dermatological patients had PD simultaneously, 111 (54%) of whom had at least one type of skin malignancy: melanoma (n=22), basal cell carcinoma (BCC) (n=82), or squamous cell carcinoma (SCC) (n=36) (in some patients, multiple skin tumours were identified). Compared to the age- and sex-matched control group, patients with PD had a significantly lower risk for basal cell carcinoma (OR, 0.65; 95% CI, 0.47\u20130.89, p=0.0076) and for all skin tumours (OR, 0.74; 95% CI, 0.56\u20130.98, p=0.0392) but not for melanoma.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>We found a decreased risk of all skin tumours and basal cell carcinoma and an unchanged risk of melanoma among patients with PD. However, it should be kept in mind that some large-scale meta-analyses suggest a higher incidence of melanoma after a diagnosis of PD, indicating the importance of skin examination in this vulnerable population.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fonc.2023.1142170","type":"journal-article","created":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T06:07:16Z","timestamp":1684476436000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Cutaneous malignancies in patients with Parkinson\u2019s disease at a dermato-oncological university centre in Hungary"],"prefix":"10.3389","volume":"13","author":[{"given":"Veronika","family":"T\u00f3th","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefani Christina","family":"Diakoumakou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enik\u0151","family":"Kuroli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B\u00e9la","family":"T\u00f3th","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniella","family":"Kuzmanovszki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00f3zsef","family":"Szakonyi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kende K\u00e1lm\u00e1n","family":"L\u0151rincz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Be\u00e1ta","family":"Somlai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarolta","family":"K\u00e1rp\u00e1ti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P\u00e9ter","family":"Holl\u00f3","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,5,19]]},"reference":[{"key":"B1","article-title":"Multiple primary melanoma following administration of levodopa","volume":"93","author":"Skibba","year":"1972","journal-title":"Arch Pathol"},{"key":"B2","first-page":"213","article-title":"Levodopa and malignant melanoma","volume":"95","author":"Robinson","year":"1973","journal-title":"Arch Pathol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.24.4.340","article-title":"Levodopa and melanoma","volume":"24","author":"Lieberman","year":"1978","journal-title":"Neurology"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1978.03290060056015","article-title":"Levodopa therapy and malignant melanoma","volume":"240","author":"Sober","year":"1978","journal-title":"JAMA"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1980.01640330079019","article-title":"Levodopa administration and multiple primary cutaneous melanomas","volume":"116","author":"Bernstein","year":"1980","journal-title":"Arch Dermatol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3181fb4466","article-title":"Common pathogenic pathways in melanoma and Parkinson disease","volume":"75","author":"Pais\u00e1n-Ruiz","year":"2021","journal-title":"Neurology"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1111\/j.1755-148X.2009.00624.x","article-title":"Twenty-two cutaneous primary melanomas in a patient with high genetic predisposition to melanoma receiving levodopa therapy for parkinson's disease","volume":"22","author":"Charles","year":"2009","journal-title":"Pigment Cell Melanoma Res"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1097\/DAD.0000000000001807","article-title":"Melanocytic hyperactivation simulating an acral lentiginous melanoma in a patient with Parkinson disease treated by levodopa","volume":"43","author":"Porcar Saura","year":"2021","journal-title":"Am J Dermatopathol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1007\/s00702-009-0322-x","article-title":"The particular relationship between parkinson\u2019s disease and malignancy: a focus on skin cancers","volume":"116","author":"Inzelberg","year":"2009","journal-title":"J Neural Transm"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1007\/s00702-011-0580-2","article-title":"High prevalence of malignant melanoma in Israeli patients with parkinson's disease","volume":"118","author":"Inzelberg","year":"2011","journal-title":"J Neural Transm (Vienna)"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/s1353-8020(03)00040-3","article-title":"Malignant melanoma and levodopa in parkinson's disease: causality or coincidence","volume":"9","author":"Fiala","year":"2003","journal-title":"Parkinsonism Relat Disord"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1345\/aph.19150","article-title":"Levodopa therapy and the risk of malignant melanoma","volume":"34","author":"Siple","year":"2000","journal-title":"Ann Pharmacother"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1097\/01.ede.0000229445.90471.5e","article-title":"Malignant melanoma and other types of cancer preceding Parkinson disease","volume":"17","author":"Olsen","year":"2006","journal-title":"Epidemiology"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2009.05.002","article-title":"Parkinson\u2019s disease, levodopa-use and the risk of melanoma","volume":"15","author":"Vermeij","year":"2009","journal-title":"Parkinsonism Relat Disord"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1002\/mds.23246","article-title":"Comorbid cancer in parkinson's disease","volume":"25","author":"Lo","year":"2010","journal-title":"Mov Disord"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1002\/mds.22855","article-title":"Skin cancer and parkinson\u2019s disease","volume":"25","author":"Ferreira","year":"2010","journal-title":"Mov Disord"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.25912","article-title":"The association between parkinson\u2019s disease and melanoma","volume":"128","author":"Pan","year":"2011","journal-title":"Int J Cancer"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1097\/DSS.0000000000000591","article-title":"A review of the association between Parkinson disease and malignant melanoma","volume":"42","author":"Disse","year":"2011","journal-title":"Dermatol Surg"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1001\/archneurol.2010.1","article-title":"Increased melanoma risk in Parkinson disease: a prospective clinicopathological study","volume":"67","author":"Bertoni","year":"2010","journal-title":"Arch Neurol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1002\/mds.25734","article-title":"Malignant melanoma in early-treated parkinson's disease: the NET-PD trial","volume":"29","author":"Constantinescu","year":"2014","journal-title":"Mov Disord"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.12492","article-title":"Emerging trends in the epidemiology of melanoma","volume":"170","author":"Nikolaou","year":"2014","journal-title":"Br J Dermatol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurobiolaging.2016.07.013","article-title":"Rare variants analysis of cutaneous malignant melanoma genes in parkinson's disease","volume":"48","author":"Lubbe","year":"2016","journal-title":"Neurobiol Aging"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2020.00060","article-title":"Association between parkinson\u2019s disease and melanoma: putting the pieces together","volume":"12","author":"Ye","year":"2020","journal-title":"Front Aging Neurosci"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3233\/JPD-171263","article-title":"Parkinson\u2019s disease and melanoma: co-occurrence and mechanisms","volume":"8","author":"Bose","year":"2018","journal-title":"J Parkinsons Dis"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/jnci\/djv340","article-title":"PARKIN inactivation links parkinson's disease to melanoma","volume":"108","author":"Hu","year":"2015","journal-title":"J Natl Cancer Inst"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgg.2016.05.005","article-title":"Parkin somatic mutations link melanoma and parkinson's disease","volume":"43","author":"Levin","year":"2016","journal-title":"J Genet Genomics"},{"key":"B27","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1001\/jamaneurol.2014.1973","article-title":"Higher frequency of certain cancers in LRRK2 G2019S mutation carriers with Parkinson disease: a pooled analysis","volume":"72","author":"Agalliu","year":"2015","journal-title":"JAMA Neuro"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2001-3-1-reviews3002","article-title":"The synucleins","volume":"3","author":"George","year":"2002","journal-title":"Genome Biol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0045183","article-title":"The role of alpha-synuclein in melanin synthesis in melanoma and dopaminergic neuronal cells","volume":"7","author":"Pan","year":"2012","journal-title":"PloS One"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0010481","article-title":"Parkinson\u2019s disease-related protein, \u03b1-synuclein, in malignant melanoma","volume":"5","author":"Matsuo","year":"2010","journal-title":"PloS One"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1002\/acn3.381","article-title":"Red hair, MC1R variants, and risk for parkinson's disease - a meta-analysis","volume":"4","author":"Chen","year":"2017","journal-title":"Ann Clin Transl Neurol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.parkreldis.2016.06.014","article-title":"Cancer in parkinson\u2019s disease","volume":"31","author":"Tacik","year":"2016","journal-title":"Parkinsonism Relat Disord"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.27443","article-title":"Malignant melanoma, breast cancer and other cancers in patients with parkinson's disease","volume":"131","author":"Rugbjerg","year":"2012","journal-title":"Int J Cancer"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3233\/JPD-202474","article-title":"No evidence for a causal relationship between cancers and parkinson's disease","volume":"11","author":"Senkevich","year":"2021","journal-title":"J Parkinsons Dis"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurobiolaging.2013.12.020","article-title":"Susceptibility loci for pigmentation and melanoma in relation to parkinson's disease","volume":"35","author":"Dong","year":"2014","journal-title":"Neurobiol Aging"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1111\/ene.15069","article-title":"Cancer risk in Parkinson disease: an updated systematic review and meta-analysis","volume":"28","author":"Leong","year":"2021","journal-title":"Eur J Neurol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.18632\/aging.203932","article-title":"Parkinson's disease and cancer: a systematic review and meta-analysis on the influence of lifestyle habits, genetic variants, and gender","volume":"14","author":"Lee","year":"2022","journal-title":"Aging (Albany NY)"},{"key":"B38","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1159\/000356498","article-title":"Inverse and direct cancer comorbidity in people with central nervous system disorders: a meta-analysis of cancer incidence in 577,013 participants of 50 observational studies","volume":"83","author":"Catal\u00e1-L\u00f3pez","year":"2014","journal-title":"Psychother Psychosom"},{"key":"B39","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s40035-015-0044-y","article-title":"The association between parkinson\u2019s disease and melanoma: a systematic review and meta-analysis","volume":"4","author":"Huang","year":"2015","journal-title":"Trans Neurodegeneration"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e31821e554e","article-title":"Meta-analysis of the relationship between Parkinson disease and melanoma","volume":"76","author":"Liu","year":"2011","journal-title":"Neurology"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13040587","article-title":"Risk of nonmelanoma skin cancers and parkinson's disease - meta-analysis and systematic review","volume":"13","author":"Krasowska","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.13070\/rs.en.1.800","article-title":"Basal cell carcinoma and squamous cell carcinoma in a patient with Parkinson disease","volume":"1","author":"Dobrev","year":"2014","journal-title":"Research"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.ad.2009.05.002","article-title":"Melanomas and basal cell carcinomas in a patient with Parkinson disease","volume":"101","author":"Hiraldo","year":"2010","journal-title":"Actas Dermosifiliogr"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1700\/1125.12418","article-title":"LDOC1 gene expression in two patients with head and neck squamous cell carcinomas and parkinson's disease","volume":"98","author":"Salemi","year":"2012","journal-title":"Tumori"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1007\/s13577-011-0021-4","article-title":"PARP1 and CASP3 gene expression in a patient with multiple head and neck squamous cell carcinoma and Parkinson disease","volume":"26","author":"Calogero","year":"2011","journal-title":"Hum Cell"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1358\/dot.2011.47.3.1519657","article-title":"Cancer and parkinson's disease: the odd couple","volume":"47","author":"Gao","year":"2011","journal-title":"Drugs Today (Barc)"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1159\/000487855","article-title":"Parkinson's disease, melanoma, and keratinocyte carcinoma: a population-based study","volume":"50","author":"Lerman","year":"2018","journal-title":"Neuroepidemiology"},{"key":"B48","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.parkreldis.2020.11.017","article-title":"Parkinson's disease and skin","volume":"82","author":"Niemann","year":"2021","journal-title":"Parkinsonism Relat Disord"},{"key":"B49","doi-asserted-by":"publisher","first-page":"e10836","DOI":"10.7759\/cureus.10836","article-title":"Dermatological manifestations of parkinson's disease: clues for diagnosis","volume":"12","author":"Shahid","year":"2020","journal-title":"Cureus"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1159\/000331489","article-title":"Analysis of parkinson's disease and subsequent cancer risk in Taiwan: a nationwide population-based cohort study","volume":"37","author":"Sun","year":"2011","journal-title":"Neuroepidemiology"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2014.06.018","article-title":"Differential risks of cancer types in people with parkinson's disease: a national record-linkage study","volume":"50","author":"Ong","year":"2014","journal-title":"Eur J Cancer"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2015.1752","article-title":"Association between Parkinson disease and risk of cancer in Taiwan","volume":"1","author":"Lin","year":"2015","journal-title":"JAMA Oncol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1007\/s10552-009-9497-6","article-title":"Parkinson's disease and cancer risk: a systematic review and meta-analysis","volume":"21","author":"Bajaj","year":"2010","journal-title":"Cancer Causes Control"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1159\/000443794","article-title":"Increased odds of melanoma: parkinson's disease, essential tremor, dystonia versus controls","volume":"46","author":"Shalaby","year":"2016","journal-title":"Neuroepidemiology"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1001\/archneurol.2012.2261","article-title":"Shared predispositions of parkinsonism and cancer: a population-based pedigree-linked study","volume":"69","author":"Kareus","year":"2012","journal-title":"Arch Neurol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3181bd13a1","article-title":"Family history of melanoma and Parkinson disease risk","volume":"73","author":"Gao","year":"2009","journal-title":"Neurology"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-07-0038","article-title":"A prospective cohort study of cancer incidence following the diagnosis of parkinson's disease","volume":"16","author":"Driver","year":"2007","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1002\/mds.21273","article-title":"Malignant melanoma in early parkinson's disease: the DATATOP trial","volume":"22","author":"Constantinescu","year":"2007","journal-title":"Mov Disord"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2009.11.005","article-title":"Cancer risk in association with Parkinson disease: a population-based study","volume":"16","author":"Becker","year":"2010","journal-title":"Parkinsonism Relat Disord"},{"key":"B60","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1093\/aje\/kwt232","article-title":"Parkinson's disease and cancer: a register-based family study","volume":"179","author":"Wirdefeldt","year":"2014","journal-title":"Am J Epidemiol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1097\/EDE.0b013e3181fe21a8","article-title":"Parkinson Disease and malignant melanoma in first-degree relatives of patients with early-onset melanoma","volume":"22","author":"Olsen","year":"2011","journal-title":"Epidemiology"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6602279","article-title":"Atypical cancer pattern in patients with parkinson's disease","volume":"92","author":"Olsen","year":"2005","journal-title":"Br J Cancer"},{"key":"B63","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.parkreldis.2016.04.028","article-title":"Cancer incidence among parkinson's disease patients in a 10-yrs time-window around disease onset: a large-scale cohort study","volume":"28","author":"Peretz","year":"2016","journal-title":"Parkinsonism Relat Disord"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410170514","article-title":"Low cancer rates among patients with parkinson's disease","volume":"17","author":"Jansson","year":"1985","journal-title":"Ann Neurol"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-046329","article-title":"Parkinson's disease and cancer: a systematic review and meta-analysis of over 17 million participants","volume":"11","author":"Zhang","year":"2021","journal-title":"BMJ Open"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1002\/mds.21575","article-title":"Skin cancers and precancerous lesions in parkinson's disease patients","volume":"22","author":"Ferreira","year":"2007","journal-title":"Mov Disord"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2015.1188","article-title":"Trends in basal cell carcinoma incidence and identification of high-risk subgroups, 1998-2012","volume":"151","author":"Asgari","year":"2015","journal-title":"JAMA Dermatol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1590\/abd1806-4841.20153465","article-title":"Squamous cell cancer\u201331-year epidemiological study in a city of south Brazil","volume":"90","author":"Nasser","year":"2015","journal-title":"Bras Dermatol"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2012.04483.x","article-title":"Host risk factors for the development of multiple non-melanoma skin cancers","volume":"27","author":"Qureshi","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2003.020982","article-title":"Are men at greater risk for parkinson\u2019s disease than women","volume":"75","author":"Wooten","year":"2004","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1007\/s12253-013-9647-8","article-title":"Risk of subsequent primary tumor development in melanoma patients","volume":"19","author":"T\u00f3th","year":"2013","journal-title":"Pathol Oncol Res"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-2115","article-title":"Role of age and sex in the diagnosis of early-stage malignant melanoma: a cross-sectional study","volume":"95","author":"Moreno-Ram\u00edrez","year":"2015","journal-title":"Acta Derm Venereol"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.23.4799","article-title":"Final version of 2009 AJCC melanoma staging and classification","volume":"27","author":"Balch","year":"2009","journal-title":"J Clin Oncol"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2023.1142170\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T06:07:22Z","timestamp":1684476442000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2023.1142170\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,19]]},"references-count":73,"alternative-id":["10.3389\/fonc.2023.1142170"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2023.1142170","relation":{},"ISSN":["2234-943X"],"issn-type":[{"type":"electronic","value":"2234-943X"}],"subject":[],"published":{"date-parts":[[2023,5,19]]},"article-number":"1142170"}}